Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies
Top Cited Papers
- 31 August 2013
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 25 (4), 477-483
- https://doi.org/10.1016/j.coi.2013.05.006
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Human Monocytes Differentiate into Dendritic Cells Subsets that Induce Anergic and Regulatory T Cells in SepsisPLOS ONE, 2012
- IL-7 in human health and diseaseSeminars in Immunology, 2012
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerThe New England Journal of Medicine, 2012
- Myeloid-Derived Suppressor Cells Evolve during Sepsis and Can Enhance or Attenuate the Systemic Inflammatory ResponseInfection and Immunity, 2012
- A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1JCI Insight, 2012
- A prospective analysis of lymphocyte phenotype and function over the course of acute sepsisCritical Care, 2012
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011
- Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patientsCritical Care, 2011
- Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysisCritical Care, 2009
- Cytomegalovirus Reactivation in Critically Ill Immunocompetent PatientsJAMA, 2008